Group Papers / Other

Purpose: To highlight the groundbreaking research on B-cell depletion therapy for severely affected Myalgic Encephalomyelitis (ME) patients, emphasizing the potential benefits, clinical findings, and future research directions. Key Points: Accidental Discovery: Norwegian oncologists, Dr. Øystein Fluge and Professor Olav Mella, observed “major symptom relief” in a cancer patient with severe ME undergoing chemotherapy. This led…

Purpose: To establish that Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a physical disorder, countering efforts to classify it as a psychiatric or behavioral condition. Key Points: WHO and Official Recognition: The WHO confirmed in 2014 that ME/CFS is not classified as a mental or behavioral disorder in ICD-10 or proposed for ICD-11. The UK government…

Purpose: To discuss the clinical features, potential causes, and management strategies for Myalgic Encephalomyelitis (ME), emphasizing the importance of early rest and understanding of the condition. Key Points: Clinical Features: ME often follows a viral infection and presents with persistent fatigue, muscle weakness, headaches, blurred vision, and neurological symptoms such as difficulty concentrating and memory…

Purpose: To examine the long-term impacts of Myalgic Encephalomyelitis (ME), its parallels with Post-Polio Syndrome, and the need for improved recognition, research, and management strategies. Key Points: Nature of ME: ME is a chronic neurological illness caused by enteroviral infections, leading to multi-system impacts, including skeletal, cardiac, and endocrine organ damage. Symptoms include overwhelming fatigue,…